🔎 Trials Near Me

Почетна › Steatotna bolest jetre › Тексас › San Antonio

Kliničke studije za Steatotna bolest jetre u gradu San Antonio, TX

16 studija za Steatotna bolest jetre traži učesnike na lokacijama u gradu San Antonio i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Тражи се учесникФаза 2
  • GSK Investigational Site, San Antonio
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06613698

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Тражи се учесникФаза 3
  • Akero Clinical Study Site, San Antonio
  • Akero Clinical Study Site, San Antonio
  • Akero Clinical Study Site, San Antonio
  • и још 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Тражи се учесникФаза 2
  • American Research Corporation at The Texas Liver Institute, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07631637

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Тражи се учесникФаза 2
  • Quality Research, Inc., San Antonio
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • Pinnacle Clinical Research, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Тражи се учесникФаза 2
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT06920043

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Тражи се учесникФаза 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Тражи се учесникФаза 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07701993

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

Тражи се учесникФаза 1
  • GSK Investigational Site, San Antonio
Узраст од 18 до 70 · Оба пола · Ажурирано 5. 11. 2026. · NCT07358546

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Тражи се учесникОпсервациона студија
  • Endeavor Clinical Trials, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07122700

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Тражи се учесникФаза 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Тражи се учесникФаза 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • и још 2
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Тражи се учесникФаза 3
  • American Research Corporation at Texas Liver Institute, San Antonio
  • Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
  • IMA Clinical Research San Antonio, San Antonio
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Тражи се учесникФаза 2
  • American Research Corporation at The Texas Liver Institute, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 9. 2026. · NCT07527910

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Тражи се учесникФаза 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 9. 2026. · NCT07221188

Quantifying Hepatic Mitochondrial Fluxes in Humans

Тражи се учесникФаза 4
  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Узраст од 18 до 80 · Оба пола · Ажурирано 17. 8. 2026. · NCT05305287

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Тражи се учесникФаза 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227

Studije za Steatotna bolest jetre u drugim gradovima

Ostale studije u gradu San Antonio

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.